DLA Piper leverages a wide network that spans several UK offices as well as presences in Europe, Southeast Asia, and the United States to act on a diverse array of transactions both on the Main Market and AIM as well as on international exchanges. The team has extensive experience guiding UK clients through dual listings, and it also frequently acts on cross-border share transactions and takeover deals. The UK team is jointly led by Martin Penn, who is well-versed in advising clients in the tech and life sciences sectors on primary and secondary offerings as well as on ECM regulatory matters, and Robert Newman, who focuses on guiding UK regional clients through ECM transactions.
Legal 500 redaktioneller Kommentar
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
- 'Particularly impressed by pragmatism, client focus, and humanity. I can’t think of better individuals to have to spend so much time with on complex, intensive matters.'
Kernmandanten
- Dechra Pharmaceuticals plc
- Aptitude Software Group plc
- PureTech Health plc
- Keller Group plc
- Philip Morris International
- Hutchison China Meditech
- Learning Technologies Group plc
- RPS Group plc
- Medica Group plc
- John Menzies plc
Highlight-Mandate
- Advised Dechra Pharmaceuticals PLC on a recommended cash offer by Freya Bidco Limited which implies an enterprise value of £4.88bn.
- Advised Medica on a potential take-private by Moonlight Bidco in an all-cash deal worth £269m.
- Advised YouGov plc on the acquisition of GfK CP, the European Consumer Panel Business of Germany based GfK SE, for a headline purchase price of €315m.
Anwält*innen
Praxisleitung
Martin Penn; Robert Newman